Search Results

248 Results for "cormedix".

Sort By

Press Releases

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

November 4, 2024
·
1 min read
Policy

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

CorMedix Inc. announced that the U.S. Food and Drug Administration has provided feedback to the Company’s request to discuss development plans for additional indications for DefenCath.

June 18, 2024
·
4 min read
Pharm Country

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

CorMedix Inc. announced that the Center for Medicare & Medicaid Services has determined that DefenCath® qualifies for pass-through status under the hospital Out-Patient Prospective Payment System.

June 6, 2024
·
3 min read
Business

CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

CorMedix Inc. today announced that it has entered into a multi-year commercial supply contract with a top tier midsized dialysis provider for the supply of DefenCath ® (taurolidine and heparin).

May 28, 2024
·
3 min read
Press Releases

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

October 25, 2024
·
4 min read
Press Releases

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

October 9, 2024
·
4 min read
Press Releases

CorMedix Inc. Announces New Commercial Agreement

September 9, 2024
·
4 min read
Press Releases

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

October 30, 2024
·
8 min read
Business

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

September 13, 2024
·
1 min read
Pharm Country

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

CorMedix Inc. today announced that the Center for Medicare & Medicaid Services (CMS) has determined that DefenCath ® meets the criteria for a Transitional Drug Add-On Payment (TDAPA) in the anti-infective functional category, beginning on July 1, 2024.

April 19, 2024
·
4 min read